We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





2021 AACC to Showcase Cutting-Edge Science and Technology Shaping Future of Laboratory Medicine

By LabMedica International staff writers
Posted on 31 Aug 2021
The 2021 American Association for Clinical Chemistry (AACC; Washington, DC, USA) Annual Scientific Meeting & Clinical Lab Expo will be a live event that will explore the cutting-edge science and technology shaping the future of laboratory medicine.

Every year, the global laboratory medicine community comes together as one at the AACC Annual Scientific Meeting & Clinical Lab Expo to collaborate and create system-wide changes that improve patient outcomes and quality of life for all. More...
AACC's annual meeting is the world's largest lab medicine conference with nearly 20,000 participants from more than 100 countries. Each year AACC hosts the conference in a new city that provides an exciting backdrop for the premier meeting in the field of laboratory medicine. AACC has moved the location of its 2021 annual meeting from Anaheim, California to Atlanta, Georgia and also changed the meeting dates to one week later: September 26-30, 2021.

The AACC Annual Scientific Meeting includes hundreds of educational sessions on a wide variety of timely laboratory medicine topics. AACC's annual meeting offers five days packed with opportunities to learn about exciting science. Plenary sessions will feature expert presentations on using tumor DNA in the blood to diagnose and monitor cancer, reducing the risk of heart disease, transparency in healthcare delivery, the latest advances that could lead to a cure for HIV, and new tests and treatment for infection.

Attendees will not only benefit from a stunning lineup of expert speakers and scientific sessions, but can also see a vast array of emerging technologies and products at the world's largest exhibition for in vitro diagnostics. The Clinical Lab Expo is the exhibit tradeshow of the AACC Annual Scientific Meeting and will host exhibitors in all areas of clinical laboratory science. At this year’s AACC Clinical Lab Expo, more than 700 exhibitors will display the latest diagnostic technology, including but not limited to mobile health, molecular diagnostics, mass spectrometry, point-of-care, and automation.

The AACC Annual Scientific Meeting will hold Lecture Series Presentations where attendees will learn about the latest technologies and services in convenient, 20-minute presentations covering topics such as “The Challenge and Promise of Launching COVID-19 Testing in Small and Non-Traditional Labs.” Additionally, Industry Workshop presentations will be held on new diagnostic breakthroughs and critical lab medicine topics such as “Mitigating Pre-analytical Errors in Point-of-Care Blood Gas Testing With a Total Quality Assurance Program” and “COVID-19 Testing at the Point of Care: New Platform for High Sensitivity Antigen and Antibody Testing,” among others.

Related Links:
American Association for Clinical Chemistry


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
Automated Clinical Chemistry Analyzer
Envoy 500+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








ADLM

Channels

Molecular Diagnostics

view channel
Image: The researchers Manel Pérez Pons y Carlos Rodriguez Muñoz at the IRBLleida laboratory (Photo courtesy of IRBLleida)

New Blood RNA Markers Help Advance Precision Medicine for Respiratory Patients

Risk stratification in hospitalized respiratory disease, particularly among older adults with COVID-19, remains challenging despite rich clinical datasets. Blood-based non-coding RNA biomarkers are promising,... Read more

Microbiology

view channel
Image: The “broth” used to monitor red blood cell depletion in whole blood spiked with one colony-forming-unit of E. coli bacteria, each incubated at different orbital shaking speeds—left to right: 0 RPM, 65 RPM, 120 RPM and 200 RPM—after four hours of incubation. This culturing raises a bacteria-rich, plasma-like layer of bacteria to the top of the vials, while clusters of stuck blood cells known as a Rouleaux formation sink to the bottom. (Image Credit: Pak Kin Wong)

New Diagnostic Workflow Identifies Bloodstream Pathogens and Antibiotic Response in Hours

Sepsis is a life-threatening complication of infection that affects more than 1.5 million patients annually in the United States and contributes to roughly one in three in-hospital deaths.... Read more

Pathology

view channel
Image: Researchers evaluated AI models that quantify tumor-infiltrating lymphocytes (TIL) on routine breast tissue slides, where higher TIL levels reflect stronger antitumor response and improved breast cancer outcomes (Image Credit: Shutterstock)

AI Matches Pathologists in Predicting Breast Cancer Prognosis from Immune Cells

Breast cancer is the most common cancer in Australian women, with more than 20,000 cases each year. Prognosis can be informed by counting tumor-infiltrating lymphocytes (TILs) on routine pathology slides,... Read more

Industry

view channel
Image: RaDaR ST uses a tumor-informed approach that identifies up to 48 patient-specific variants through whole-exome sequencing and tracks those variants in plasma to detect circulating tumor DNA (ctDNA) at very low variant allele fractions (VAFs) (Photo courtesy of Neogenomics)

Tumor-Informed MRD Assay Gains Medicare Coverage for Immunotherapy Monitoring

NeoGenomics’ RaDaR ST molecular residual disease (MRD) assay has received expanded coverage from the Centers for Medicare & Medicaid Services’ Molecular Diagnostic Services Program (MolDX) for monitoring... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.